These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7397067)

  • 1. Effects of tranylcypromine stereoisomers on monamine oxidation in man.
    Reynolds GP; Rausch WD; Riederer P
    Br J Clin Pharmacol; 1980 May; 9(5):521-3. PubMed ID: 7397067
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranylcypromine ('Parnate') overdose: measurement of tranylcypromine concentrations and MAO inhibitory activity and identification of amphetamines in plasma.
    Youdim MB; Aronson JK; Blau K; Green AR; Grahame-Smith DG
    Psychol Med; 1979 May; 9(2):377-82. PubMed ID: 472083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranylcypromine isomers in the treatment of Parkinson's disease. Biochemical effects.
    Reynolds GP; Riederer P
    Int Pharmacopsychiatry; 1981; 16(1):30-3. PubMed ID: 7298269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine metabolism in human brain: effect of monoamine oxidase inhibition in vitro by (-)deprenyl and (+) and (-) tranylcypromine.
    Reynolds GP; Riederer P; Rausch WD
    J Neural Transm Suppl; 1980; (16):173-8. PubMed ID: 6776236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of transamine and iprazid on the monamine oxidase activity in midbrain and optic lobes of the brain].
    Gotovtseva EP
    Ukr Biokhim Zh; 1968; 40(1):7-10. PubMed ID: 5700114
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of purified rat liver mitochondrial monamine oxidase by trans-2-phenylcyclopropylamine.
    Guha SR
    Biochem Pharmacol; 1966 Feb; 15(2):161-8. PubMed ID: 5943317
    [No Abstract]   [Full Text] [Related]  

  • 7. Tranylcypromine isomers and Parkinson's disease: new aspects of an old drug.
    Reynolds GP; Riederer P; Sandler M
    J R Soc Med; 1981 Sep; 74(9):649-52. PubMed ID: 7288807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of single doses of tranylcypromine on platelet MAO and amine uptake in normal subjects.
    Gentil V; Alevizos B; Lader M
    Biochem Pharmacol; 1978; 27(8):1197-201. PubMed ID: 697920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination and comparison of the plasma and urine concentrations in men given tranylcypromine stereoisomers].
    Lang A; Geissler HE; Mutschler E
    Arzneimittelforschung; 1979; 29(1):154-7. PubMed ID: 582109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tranylcypromine stereoisomers on depressive syndromes.
    Rüther E; Jungkunz G; Greil W; Zimmer R
    Mod Probl Pharmacopsychiatry; 1983; 19():203-10. PubMed ID: 6865964
    [No Abstract]   [Full Text] [Related]  

  • 11. Tranylcypromine lowers human platelet MAO B activity but not concentration.
    Fritz RR; Malek-Ahmadi P; Rose RM; Denney RM; Abell CW
    Biol Psychiatry; 1983 Jun; 18(6):685-94. PubMed ID: 6871302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of amine oxidase for optically active substrates and inhibitors.
    PRATESI P; BLASCHKO H
    Br J Pharmacol Chemother; 1959 Jun; 14(2):256-60. PubMed ID: 13662585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidation in different regions of rat & goat brain.
    Guha SR; Bose AR; Ghosh SK
    Indian J Biochem; 1971 Sep; 8(3):170-1. PubMed ID: 4257874
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine oxidase inhibition and recovery in the mouse brain at various ages after birth.
    Samsa JM; Baker PC; Hoff KM
    Biol Neonate; 1979; 35(5-6):249-54. PubMed ID: 476197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR; Olivieri A; Ramsay RR; Holt A
    Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 17. Rate of metabolism of adrenaline and 5-hydroxytryptamine by blood platelets.
    Lahovaara S; Paasonen MK; Airaksinen MM
    Ann Med Exp Biol Fenn; 1968; 46(3):453-6. PubMed ID: 5734249
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of monamine oxidase inhibitors on qualitive alterations ( Transformation ) of the catalytic properties of amine oxidases.
    Gorkin VZ; Akopyan ZI; Veryovkina IV; Stesina LN; Samed MM
    Biochem J; 1971 Feb; 121(3):31P-32P. PubMed ID: 5000918
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts.
    Valente S; Rodriguez V; Mercurio C; Vianello P; Saponara B; Cirilli R; Ciossani G; Labella D; Marrocco B; Monaldi D; Ruoppolo G; Tilset M; Botrugno OA; Dessanti P; Minucci S; Mattevi A; Varasi M; Mai A
    Eur J Med Chem; 2015 Apr; 94():163-74. PubMed ID: 25768700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.